Combined Behavioral/Pharmacological Therapy for Insomnia

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Duke University
• Collaborator: National Institute of Mental Health (NIMH)
• Treatments: Zolpidem

Criteria

Inclusion Criteria:

• be between 21 and 75 years of age

• have a mean total nocturnal wake time of > 60 min./night

• have a history of insomnia > 6 months

• have a history of one or more poor sleep hygiene practices such as taking 3 or more naps/week, varying bed times or wake times by > 2 hrs. from day to day, or routinely lying in bed awake for periods > 30 min

Exclusion Criteria:

• pregnant women

• the terminally ill

• individuals with other medical conditions (e.g. chronic pain disorders, etc.) that compromise sleep

• individuals with major psychiatric diagnoses

• persons with hypnotic-dependent insomnia

• subjects on antidepressants or anxiolytics

• subjects with evidence of sleep apnea